DS InPharmatics LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DS InPharmatics LLC - overview
Established
2007
Location
Harleysville, PA, US
Primary Industry
Biotechnology
About
Based in Pennsylvania, US, and established in 2007, DS InPharmatics LLC provides advisory services to pharmaceutical and biopharmaceutical companies with regard to regulatory drug development. Edward Narke and Anthony Durning were the founders of the company. In April 2021, DS InPharmatics LLC was acquired by Groupe ProductLife S. A.
The company provides regulatory and compliance consultancy services to biotech companies which include regulatory affairs, chemistry manufacturing and controls, and quality assurance for the development of pharmaceutical and biopharmaceutical products. Following the acquisition in April 2021, DS InPharmatics LLC will partner with Groupe ProductLife S. A. to help the company strengthen its positioning in the United States as well as to further expand its service offerings for its customers.
Current Investors
Groupe ProductLife S.A.S.
Primary Industry
Biotechnology
Sub Industries
Consulting Services, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.dsinpharmatics.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
DS InPharmatics LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | DS InPharmatics LLC | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.